9-128632280-G-GGCATGC
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2PM4PP3PP5_Very_Strong
The NM_001130438.3(SPTAN1):c.6923_6928dupGCATGC(p.Arg2308_Met2309dup) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001130438.3 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTAN1 | NM_001130438.3 | MANE Select | c.6923_6928dupGCATGC | p.Arg2308_Met2309dup | disruptive_inframe_insertion | Exon 53 of 57 | NP_001123910.1 | ||
| SPTAN1 | NM_001375318.1 | c.7022_7027dupGCATGC | p.Arg2341_Met2342dup | disruptive_inframe_insertion | Exon 55 of 59 | NP_001362247.1 | |||
| SPTAN1 | NM_001375310.1 | c.7010_7015dupGCATGC | p.Arg2337_Met2338dup | disruptive_inframe_insertion | Exon 54 of 58 | NP_001362239.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTAN1 | ENST00000372739.7 | TSL:1 MANE Select | c.6923_6928dupGCATGC | p.Arg2308_Met2309dup | disruptive_inframe_insertion | Exon 53 of 57 | ENSP00000361824.4 | ||
| SPTAN1 | ENST00000372731.8 | TSL:1 | c.6908_6913dupGCATGC | p.Arg2303_Met2304dup | disruptive_inframe_insertion | Exon 52 of 56 | ENSP00000361816.4 | ||
| SPTAN1 | ENST00000358161.9 | TSL:1 | c.6848_6853dupGCATGC | p.Arg2283_Met2284dup | disruptive_inframe_insertion | Exon 51 of 55 | ENSP00000350882.6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 5 Pathogenic:3
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP4.
not provided Pathogenic:2
c.6923_6928dupGCATGC: p.Arg2308_Met2309dup (R2308_M2309dup) in exon 53 of the SPTAN1 gene (NM_001130438.1). The normal sequence with the bases that are duplicated in braces is: CATG{CGCATG}. The c.6923_6928dupGCATGC mutation in the SPTAN1 gene has been previously reported as a de novo mutation in an individual with early-onset West syndrome and cerebellar hypomyelination (Saitsu et al., 2010). It results in an in-frame duplication of two highly conserved amino acids in the last spectrin repeat of the protein, and functional studies indicate the c.6923_6928dupGCATGC mutation leads to the aggregation of alpha/beta spectrin heterodimers (Saitsu et al., 2010). Therefore, c.6923_6928dupGCATGC is interpreted as pathogenic. The variant is found in INFANT-EPI panel(s).
SPTAN1: PS2, PM2, PM4, PS4:Moderate, PP4
Epileptic encephalopathy Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at